全文获取类型
收费全文 | 394篇 |
免费 | 33篇 |
国内免费 | 38篇 |
专业分类
耳鼻咽喉 | 1篇 |
儿科学 | 17篇 |
妇产科学 | 12篇 |
基础医学 | 45篇 |
临床医学 | 51篇 |
内科学 | 99篇 |
皮肤病学 | 1篇 |
神经病学 | 4篇 |
特种医学 | 9篇 |
外科学 | 30篇 |
综合类 | 69篇 |
预防医学 | 22篇 |
药学 | 25篇 |
中国医学 | 5篇 |
肿瘤学 | 75篇 |
出版年
2024年 | 1篇 |
2023年 | 4篇 |
2022年 | 23篇 |
2021年 | 22篇 |
2020年 | 15篇 |
2019年 | 12篇 |
2018年 | 21篇 |
2017年 | 12篇 |
2016年 | 20篇 |
2015年 | 21篇 |
2014年 | 25篇 |
2013年 | 29篇 |
2012年 | 36篇 |
2011年 | 24篇 |
2010年 | 22篇 |
2009年 | 21篇 |
2008年 | 18篇 |
2007年 | 14篇 |
2006年 | 14篇 |
2005年 | 13篇 |
2004年 | 11篇 |
2003年 | 12篇 |
2002年 | 8篇 |
2001年 | 5篇 |
2000年 | 4篇 |
1999年 | 3篇 |
1998年 | 3篇 |
1997年 | 3篇 |
1996年 | 4篇 |
1995年 | 3篇 |
1994年 | 3篇 |
1993年 | 2篇 |
1992年 | 4篇 |
1991年 | 3篇 |
1990年 | 6篇 |
1989年 | 2篇 |
1988年 | 4篇 |
1987年 | 4篇 |
1985年 | 2篇 |
1984年 | 3篇 |
1982年 | 1篇 |
1981年 | 3篇 |
1980年 | 1篇 |
1979年 | 1篇 |
1978年 | 2篇 |
1976年 | 1篇 |
排序方式: 共有465条查询结果,搜索用时 15 毫秒
91.
92.
93.
目的 研究超声造影肝脏影像报告与数据系统2017版(CEUS LI-RADS
v2017)在甲胎蛋白(AFP)阴性的肝细胞癌(HCC)高危患者肝局灶性病变中的应用价值。方法 回顾性分析2018年1月至2021年10月在我院行CEUS检查的AFP阴性HCC高危患者108例(134个结节),采用CEUS LI-RADS v2017对结节进行分类,以组织病理学结果或增强影像学检查和随访结果为金标准,计算CEUS LI-RADS对AFP阴性患者HCC和肝内其他恶性肿瘤(OM)的诊断敏感性、特异性、阳性预测值、阴性预测值、准确率、受试者工作特征曲线下面积(AUC)。结果 AFP阴性HCC较OM小(P<0.001)。CEUS LR-5类、LR-4类、LR-3类对AFP阴性HCC的阳性预测值分别为88.37%、47.06%、12.9%。LR-5类诊断AFP阴性HCC的敏感性、特异性、准确率和AUC分别为73.07%、 93.90%、85.82%和0.87。LR-M类诊断OM的敏感性、特异性、阳性预测值、阴性预测值、准确率和AUC分别为90.91%、97.32%、86.96%、98.20%、96.27%和0.94。结论AFP阴性HCC较OM小,CEUS LI-RADS v2017对AFP阴性HCC诊断特异性较高而敏感性较低,对OM有较好的诊断价值。 相似文献
94.
目的 探讨酶联免疫吸附(ELISA)法检测血清巨噬细胞抑制因子Ⅰ(MIC-1)联合甲胎蛋白异质体3(AFP-L3)对原发性肝癌的诊断价值.方法 选择116例临床确诊的原发性肝癌患者,应用ELISA法检测患者血清MIC-1和AFP-L3含量,分析二者联合检测在原发性肝癌诊断中的价值.结果 原发性肝癌组AFP-L3浓度为(127.12±51.43)ng/ml,明显高于正常对照组的(27.11±7.26) ng/ml(P< 0.001),以AFP-L3> 38.0 ng/ml为临界值时,灵敏度为85.34%(99/116),特异度为88.33%(53/60),诊断准确度为86.36%(152/176);原发性肝癌组MIC-1浓度为(3140.43±1138.23)pg/ml,明显高于正常对照组的(701.88±302.34) pg/ml(P<0.001),灵敏度为91.38%(106/116),特异度为85.00%(51/60),诊断准确度为89.20%(157/176).二者联合检测灵敏度为83.62%(97/116),特异度为91.67%(55/60),诊断准确度为86.36%(152/176).结论 MIC-1联合AFP-L3检测可提高原发性肝癌诊断的特异度,具有一定的临床价值. 相似文献
95.
目的 探讨血清高尔基体蛋白73(GP73)与甲胎蛋白(AFP)联合检测在肝细胞癌(HCC)诊断中的价值。方法 收集2011年2月至2012年1月30例HCC患者(HCC组)、30例肝硬化患者(肝硬化组)和20例健康人(健康对照组)的血清,分别用酶联免疫吸附法(ELISA)和电化学发光免疫法(ECLIA)检测各组血清中GP73和AFP水平。结果 HCC组、肝硬化组和健康对照组血清GP73水平分别为(251.9±130.2)ng/ml、(74.7±40.6)ng/ml和(12.2±4.0)ng/ml,AFP水平分别为(141.6±158.3)ng/ml、(36.0±35.0)ng/ml和(2.2±1.5)ng/ml。GP73 检测HCC的敏感度为76.7%,特异度82.0%,约登指数58.7%,准确度80.0%。AFP检测HCC的敏感度为63.3%,特异度80.0%,约登指数43.3%,准确度68.8%。两者联合检测的敏感度为86.7%,特异度78.0%,约登指数64.7%,准确度81.3%。结论 HCC患者血清中GP73和AFP水平较高,两者联合检测可以显著提高HCC的诊断能力。 相似文献
96.
Hidetomo Sawada Katsunori Nakatani Nobuyuki Miyagi Takashi Nishiwada Akihiko Watanabe Tohru Okumura Yukishige Yamada Masahiro Tsutsumi Dai Nakae Hiroshige Nakano Yoichi Konishi 《Cancer science》1989,80(4):341-347
The liver metastatic potential of alpha-fetoprotein (AFP)-producing human gastric carcinoma (NSC-3) was examined in male, BALB/c, nude mice. Metastatic nodules in the liver were produced by intrasplenic (IS) injection of tumor cell suspension prepared by trypsinization from subcutaneous NSC-3 tumor. The serum AFP level increased exponentially after IS injection along with the growth of metastatic nodules in the liver, and a positive correlation was observed between the estimated weight of metastatic nodules and serum AFP level. To investigate the effect of liver damage by carbon tetrachloride (CCI4 ) on the metastatic potential of NSC-3 cells injected intrasplenlcally, the mice were divided into 4 groups: Group 1 received IS injection of 1×106 of NSC-3 cells without CCI4 , treatment; Groups 2, 3 and 4 received IS injection 7 days, 2 days and 1 day after CCI4 treatment, respectively. All mice were killed 64 days after IS injection. The incidence of liver metastasis was 80% in Group 1, but 100% in Groups 2, 3 and 4. The mean numbers of metastatic nodules per liver were 4.2 in Group 1, 16.8 in Group 2, 18.0 in Group 3 and 44.5 in Group 4. Significant differences in the mean numbers of metastatic nodules were observed between Group 4 and the other groups. It was clearly demonstrated that the metastatic potential of AFP-producing human gastric carcinoma cells (NSC-3) is enhanced in the situation prevailing after liver parenchymal cells are damaged by CCI4 . 相似文献
97.
Juhani Rapola 《Pediatric nephrology (Berlin, Germany)》1990,4(2):168-168
The editors invite questions for this section 相似文献
98.
A. Hokama M. Yamasato N. Tokumine B. Nakama Y. Muto T. Toda Y. Shingaki K. Hirayama 《Pediatric surgery international》1991,6(6):448-450
A 7-year-old girl had a huge immature grade 2 teratoma of the left ovary with peritoneal gliomatosis and elevated serum alpha-fetoprotein (AFP). The serum AFP level reached 3543 ng/ml and returned to normal after left salpingo-oophorectomy and chemotherapy. Twenty-two months later, a second mature teratoma was removed from the left subdiaphragmatic region. The AFP level had been within the normal range and the patient had been symptom-free for 3 years following the previous operation. AFP was positive in the tubular epithelium of the immature tissues on immunohistochemical study.
Offprint requests to: A. Hokama 相似文献
99.
Hao Xing Yi-Jie Zheng Jun Han Han Zhang Zhen-Li Li Wan-Yee Lau Feng Shen Tian Yang 《Hepatobiliary & pancreatic diseases international : HBPD INT》2018,17(6):487-495
Background: As a promising biomarker of hepatocellular carcinoma(HCC), protein induced by vitamin K absence or antagonist-Ⅱ(PIVKA-Ⅱ) has been studied extensively. However, its diagnostic capability varies across HCC studies. This study aimed to compare the performance of PIVKA-Ⅱ with alpha-fetoprotein(AFP) in the diagnosis of HCC. Data sources: A systematic literature search was conducted to identify the studies from MEDLINE, Embase and Cochrane Library Databases, which were published up to December 20, 2017 to compare the diagnostic capability of PIVKA-Ⅱ and AFP for HCC. The data were pooled using random effects model. Pooled sensitivity and specificity were calculated. Summary receiver operating characteristic curve(ROC) was employed to evaluate the diagnostic accuracy of each marker. Results: Thirty-one studies were included. The pooled sensitivity(95% CI) of PIVKA-Ⅱ and AFP was 0.66(0.65–0.68) and 0.66(0.65–0.67), respectively in diagnosis of HCC; and the corresponding pooled specificity(95% CI) was 0.89(0.88–0.90) and 0.84(0.83–0.85), respectively. The area under the ROC curve(AUC) of PIVKA-Ⅱ and AFP was 0.856(0.817–0.895) and 0.770(0.728–0.811), respectively. Subgroup analysis showed that PIVKA-Ⅱ was superior to AFP in terms of the AUC for both small HCC( 3 cm) [0.863(0.825–0.901) vs 0.717(0.658–0.776)] and large HCC( ≥ 3 cm) [0.854(0.811–0.897) vs 0.729(0.682–0.776)]; for American [0.926(0.897–0.955) vs 0.698(0.594–0.662)], European [0.772(0.743–0.801) vs 0.628(0.594–0.662)], Asian [0.838(0.812–0.864) vs 0.785(0.764–0.806)] and African [0.812(0.794–0.840) vs 0.721(0.675–0.767)] HCC patients; and for HBV-related [0.909(0.866–0.951) vs 0.714(0.673–0.755)] and mixed-etiology [0.847(0.821–0.873) vs 0.794(0.772–0.816)] HCC. Conclusion: This meta-analysis indicates that PIVKA-Ⅱ is better than AFP in terms of the accuracy for diagnosing HCC, regardless of tumor size, patient ethnic group, or HCC etiology. 相似文献
100.
James N. Riggins William Corey Alfred N. Fonteh Michael G. Harrington 《Disease markers》2010,28(3):125-135
Chronic hepatitis increases the risk of hepatocellular carcinoma (HCC). To test whether circulating proteins reflect hepatic carcinogenesis, sera from patients and controls were albumin depleted, enriched for glycoproteins, digested with trypsin, and subjected to reverse phase chromatography and tandem mass spectrometry. Alpha-fetoprotein enhancer binding protein (AFPebp), a tumor suppressor, was repeatedly identified in sera from chronic HBV hepatitis patients. We independently identified and quantified AFPebp with a deuterated, phenylisocyanate-labeled synthetic peptide standard. Elevated AFPebp levels in sera from chronic HBV hepatitis patients decreased as cancer developed. These data suggest that rising AFPebp levels in chronic HBV hepatitis may be protective, while falling levels may contribute to HCC development. 相似文献